| Literature DB >> 29163457 |
Tao Xu1, Xu-Yang Wang1, Peng Cui1, Yu-Meng Zhang1, Wen-Hong Zhang1, Ying Zhang1,2.
Abstract
The opportunistic pathogen Staphylococcus aureus has become an increasing threat to public health. While the Agr quorum sensing (QS) system is a master regulator of S. aureus virulence, its dysfunction has been frequently reported to promote bacteremia and mortality in clinical infections. Here we show that the Agr system is involved in persister formation in S. aureus. Mutation of either agrCA or agrD but not RNAIII resulted in increased persister formation of stationary phase cultures. RNA-seq analysis showed that in stationary phase AgrCA/AgrD and RNAIII mutants showed consistent up-regulation of virulence associated genes (lip and splE, etc.) and down-regulation of metabolism genes (bioA and nanK, etc.). Meanwhile, though knockout of agrCA or agrD strongly repressed expression of phenol soluble modulin encoding genes psmα1-4, psmβ1-2 and phenol soluble modulins (PSM) transporter encoding genes in the pmt operon, mutation of RNAIII enhanced expression of the genes. We further found that knockout of psmα1-4 or psmβ1-2 augmented persister formation and that co-overexpression of PSMαs and PSMβs reversed the effects of AgrCA mutation on persister formation. We also detected the effects on persister formation by mutations of metabolism genes (arcA, hutU, narG, nanK, etc.) that are potentially regulated by Agr system. It was found that deletion of the ManNAc kinase encoding gene nanK decreased persister formation. Taken together, these results shed new light on the PSM dependent regulatory role of Agr system in persister formation and may have implications for clinical treatment of MRSA persistent infections.Entities:
Keywords: Agr; Staphylococcus aureus; antibiotic; persister formation; sialic metabolism
Year: 2017 PMID: 29163457 PMCID: PMC5681930 DOI: 10.3389/fmicb.2017.02189
Source DB: PubMed Journal: Front Microbiol ISSN: 1664-302X Impact factor: 5.640
Strains and plasmids used in this study.
| Strain/plasmid | Specification | Reference |
|---|---|---|
| DC10B | A DC10B derivate for plasmid amplification | |
| USA500 | MRSA strain from a clinical sample | |
| Newman | An MSSA strain from a clinical sample | |
| HG003 | An MSSA strain, derivate from NCTC8325 | |
| ΔAgrCA | The | This study |
| NewmanΔAgrCA | The | This study |
| HG003ΔAgrCA | The | This study |
| ΔAgrD | The | This study |
| ΔRNAIII | The | This study |
| ΔluxS | The | This study |
| ΔArlRS | The | This study |
| ΔGraRS | The | This study |
| ΔNanK | The | This study |
| ΔAgrCAΔNanK | The | This study |
| ΔHutU | The | This study |
| ΔNarG | The | This study |
| ΔArcA | The | This study |
| ΔArcR | The | This study |
| ΔMtlD | The | This study |
| ΔImrP | The | This study |
| ΔRhbC | The | This study |
| ΔIpdC | The | This study |
| pRAB11 | ATc inducible shuttle plasmid, CmR, AmpR | |
| pMX10 | A pKOR1 derivate for gene knockout, CmR, AmpR | This study |
| pRB473 | A shuttle plasmid for complementary construction, CmR, AmpR | |
| pRBagrCA | Complementary plasmid for AgrCA | This study |
| pRBagrD | Complementary plasmid for AgrD | This study |
| pRBnanK | Complementary plasmid for NanK | This study |
| pRABpsmα | Overexpression plasmid for | This study |
| pRABpsmβ | Overexpression plasmid for | This study |
| pRABpsmαβ | Overexpression plasmid for | This study |
Genes detected for persister formation in this study.
| Gene ID | Gene | Function | Parent | Persister- | Persister- |
|---|---|---|---|---|---|
| name | strain | exponential | stationary | ||
| culture | culture | ||||
| Two-component system | USA500 | – | ↑ | ||
| Two-component system | Newman | – | ↑ | ||
| Two-component system | HG003 | – | ↑ | ||
| Signal peptide precursor | USA500 | – | ↑ | ||
| Regulatory RNA, includes | USA500 | – | ↓ | ||
| Quorum sensing | USA500 | – | – | ||
| Two-component system | USA500 | – | – | ||
| Two-component system | USA500 | – | – | ||
| ManNAc kinase | USA500 | – | ↓ | ||
| Urocanate hydratase | USA500 | – | – | ||
| Nitrate reductase | USA500 | – | – | ||
| Arginine deiminase | Newman | – | – | ||
| Arginine metabolism regulator | Newman | – | – | ||
| mannitol-1-phosphate 5-dehydrogenase | Newman | – | – | ||
| Transporter | Newman | – | – | ||
| Sialic synthase | Newman | – | – | ||
| Indole-3-pyruvate decarboxylase | Newman | – | |||
Minimum inhibitory concentration (MIC) (μg/μl) of Staphylococcus aureus strains used in this study.
| Strains | Gentamicin | Levofloxacin | Oxacillin | Vancomycin |
|---|---|---|---|---|
| USA500 | 2 | 0.5 | 0.2 | 0.5 |
| USA500ΔagrCA | 2 | 0.5 | 0.2 | 0.5 |
| USA500ΔagrD | 2 | 0.5 | 0.2 | 0.5 |
| USA500ΔRNAIII | 1 | 0.5 | 0.2 | 0.5 |
| USA500Δpsmα | 2 | 0.5 | 0.2 | 0.5 |
| USA500Δpsmβ | 2 | 0.5 | 0.2 | 0.5 |
| Newman | 1 | 0.25 | 0.05 | 0.5 |
| NewmanΔagrCA | 1 | 0.25 | 0.05 | 0.5 |
| HG003 | 1 | 0.25 | 0.1 | 0.5 |
| HG003ΔagrCA | 1 | 0.25 | 0.1 | 0.5 |